PMID: 6107091Aug 1, 1980Paper

Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy

British Heart Journal
K SwedbergI Wallentin


Fifteen patients with congestive cardiomyopathy who had improved conspicuously on chronic administration of a beta-blocker were studied after withdrawal of the drug. In six patients there was a pronounced deterioration of their clinical condition, and in all of the remaining patients there was a significant decrease in ejection fraction, and signs of compromised diastolic function with pathological apex curves and an increase in third heart sound. All these changes were reversed within a few weeks to a few months after readministration of beta-blocking drugs. This study supports the idea that an aetiological factor in congestive cardiomyopathy may be a pathological response to sympathetic stimulation which could be partly controlled by administration of beta-blocking drugs.


May 31, 1978·European Journal of Clinical Pharmacology·G JohnssonJ Wikstrand
Oct 1, 1976·Journal of Molecular and Cellular Cardiology·B J KällfeltO G Isaksson
Jun 1, 1979·Circulation·S NattelG Van Loon
Oct 1, 1975·British Heart Journal·F WaagsteinI Wallentin
Aug 1, 1980·British Heart Journal·K SwedbergI Wallentin
Sep 1, 1965·The American Journal of Medicine·C A CHIDSEYA G MORROW

❮ Previous
Next ❯


Sep 1, 1992·Clinical Cardiology·N K Wenger
Dec 16, 1998·Clinical Cardiology·M R BristowE J Eichhorn
Jan 1, 1996·Revue médicale de Liège·H Kulbertus
Apr 1, 1995·Cardiovascular Drugs and Therapy·V PanfilovG Olsson
Jan 1, 1991·Heart and Vessels. Supplement·E M GilbertM R Bristow
Jan 1, 1985·Heart and Vessels. Supplement·J B O'ConnellP J Scanlon
Jan 1, 1988·Indian Journal of Pediatrics·V Dev, R Tandon
Jun 1, 1991·Cardiovascular Drugs and Therapy·H Persson, L Erhardt
Aug 25, 2006·Current Heart Failure Reports·Rami Alharethi, Ray E Hershberger
Jun 15, 2010·Current Heart Failure Reports·Mehmet Birhan YilmazAlexandre Mebazaa
Aug 1, 1988·Journal of the American College of Cardiology·S RezkallaR Khatib
Mar 15, 1994·Journal of the American College of Cardiology·M L FisherB P Hamilton
Mar 1, 1994·Journal of the American College of Cardiology·R N DoughtyN Sharpe
May 4, 2001·The American Journal of Medicine·M Gheorghiade, E J Eichhorn
Aug 26, 1998·Progress in Cardiovascular Diseases·F Zannad
Mar 14, 1981·Lancet
Dec 29, 2000·Journal of the American College of Cardiology·B A GroenningP R Hildebrandt
Jan 1, 1984·Journal of the American College of Cardiology·P J CurrieA Pitt
Dec 22, 1999·British Journal of Clinical Pharmacology·I B Squire, D B Barnett
Sep 1, 2009·European Heart Journal·Karl Swedberg
Oct 12, 1985·British Medical Journal·D P Lipkin, P A Poole-Wilson
Aug 1, 1980·British Heart Journal·K SwedbergI Wallentin
Feb 1, 1982·British Heart Journal·D S ThompsonM M Webb-Peploe
Jul 1, 1993·British Heart Journal·Y BashirA J Camm
Jan 1, 1997·Journal of Clinical Pharmacology·T W Hash, L M Prisant
Nov 4, 2000·Expert Opinion on Investigational Drugs·D McAreaveyM J Domanski
Nov 1, 1986·Chest·P A MajidM J Sole
Apr 29, 2015·International Journal of Cardiology·Usman Tahir, Flora Sam
Apr 30, 2005·Congestive Heart Failure·William T AbrahamUNKNOWN Vasodilation in the Management of Acute Congestive Heart Failure (VMAC) Study Group
Nov 24, 1999·The American Journal of Cardiology·J R Teerlink, B M Massie
May 1, 1992·The American Journal of Medicine·E J Eichhorn
Mar 25, 1993·The American Journal of Cardiology·K Swedberg

❮ Previous
Next ❯

Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.